Skip to main content
logo
Terns Pharmaceuticals, Inc. (TERN)
May 5, 2026 - TERN was delisted (reason: acquired by MRK)
52.95
+0.02 (0.04%)
Inactive · Last trade price on May 4, 2026

Terns Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6,1144,394471401504179
Market Cap Growth
2817.95%833.82%17.33%-20.44%182.18%-
Enterprise Value
5,0954,100991353181
Last Close Price
52.9540.405.546.4910.187.07

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-----178.64
PB Ratio
5.914.371.361.571.821.11
P/TBV Ratio
6.074.371.361.571.821.11

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-----1.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.000.000.000.00-
Net Debt / Equity Ratio
-1.01-1.01-1.03-1.03-1.02-1.03
Net Debt / EBITDA Ratio
9.259.253.512.574.583.36
Net Debt / FCF Ratio
12.3912.395.093.905.713.94
Asset Turnover
-----0.01
Quick Ratio
62.0962.0922.8922.0633.4324.34
Current Ratio
62.4162.4123.1422.3933.6824.48
Return on Equity (ROE)
-14.23%-14.23%-29.56%-33.89%-27.60%-43.83%
Return on Assets (ROA)
-9.91%-9.91%-20.13%-23.08%-17.04%-23.94%
Return on Capital Employed (ROCE)
-10.90%-10.90%-29.20%-40.00%-22.30%-30.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.57%-2.19%-18.88%-22.49%-11.97%-28.08%
FCF Yield
-1.34%-1.87%-14.89%-16.82%-9.80%-23.61%
Buyback Yield / Dilution
-17.18%-17.18%-11.58%-97.76%-58.69%-7862.47%
SEC Filings: 10-K · 10-Q